Generation Bio Co bullishGeneration Bio Co. operates as a biotechnology company. The Company engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.19 USD
−126.61 M USD
5.90 M USD
42.51 M
About Generation Bio Co.
Sector
CEO
Cameron Geoffrey McDonough
Headquarters
Cambridge
Website
Founded
2016
FIGI
BBG00K698K88
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
$GBIO - important level to break$35-35.5 - breaking this level opens the road to target 1: $43
Target 2: 48 is potential if trend is broken
GBIO Bouncing Off High-Volume AreaGeneration Bio stock is triggering long on both a technical and fundamental bases. Two company insiders (board members) bought the stock in their personal accounts for a total investment of $599,000.
Additionally, GBIO is bouncing off it's high-volume areas where buyers have a history of stepping in
GBIOSHORT-TERM: Local divergence on the 4hr and potential hidden bullish divergence on the daily, over a critical support, entry has to be tactical though. (Stock market is volatile right now and not financial advice)
GBIO is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Generation Bio is an innovative genetic medicine company creating a new class of gene therapy.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GBIO is 1.11 USD — it has decreased by −2.73% in the past 24 hours. Watch Generation Bio Co. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Generation Bio Co. stocks are traded under the ticker GBIO.
GBIO stock has fallen by −1.83% compared to the previous week, the month change is a −24.65% fall, over the last year Generation Bio Co. has showed a −40.32% decrease.
We've gathered analysts' opinions on Generation Bio Co. future price: according to them, GBIO price has a max estimate of 10.00 USD and a min estimate of 5.00 USD. Watch GBIO chart and read a more detailed Generation Bio Co. stock forecast: see what analysts think of Generation Bio Co. and suggest that you do with its stocks.
GBIO reached its all-time high on Dec 2, 2020 with the price of 55.72 USD, and its all-time low was 0.75 USD and was reached on Dec 18, 2024. View more price dynamics on GBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GBIO stock is 7.69% volatile and has beta coefficient of 2.21. Track Generation Bio Co. stock price on the chart and check out the list of the most volatile stocks — is Generation Bio Co. there?
Today Generation Bio Co. has the market capitalization of 71.47 M, it has increased by 4.90% over the last week.
Yes, you can track Generation Bio Co. financials in yearly and quarterly reports right on TradingView.
Generation Bio Co. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
GBIO earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.27 USD resulting in a 15.34% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Generation Bio Co. earnings.
Generation Bio Co. revenue for the last quarter amounts to 7.55 M USD, despite the estimated figure of 1.97 M USD. In the next quarter, revenue is expected to reach 2.84 M USD.
GBIO net income for the last quarter is −15.31 M USD, while the quarter before that showed −20.43 M USD of net income which accounts for 25.05% change. Track more Generation Bio Co. financial stats to get the full picture.
No, GBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 174.00 employees. See our rating of the largest employees — is Generation Bio Co. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Generation Bio Co. EBITDA is −85.14 M USD, and current EBITDA margin is −2.14 K%. See more stats in Generation Bio Co. financial statements.
Like other stocks, GBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Generation Bio Co. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Generation Bio Co. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Generation Bio Co. stock shows the sell signal. See more of Generation Bio Co. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.